Navigation Links
Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter
Date:11/19/2008

imates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of material weaknesses in our internal controls over financial reporting; risks and costs associated with such governmental inquiries and any litigation relating thereto or to our stock option grants, procedures, and practices (including the previously disclosed private litigation); uncertainties associated with stockholder litigation; and other risks detailed from time to time in our filings with the Securities and Exchange Commission (SEC). For a detailed discussion of these and other cautionary statements, please refer to our most recent filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended April 25, 2008, and Quarterly Report on Form 10-Q for the quarterly period ended July 25, 2008.

     Contact information
     Greg Browne, CFO
     Cyberonics, Inc.
     100 Cyberonics Blvd.
     Houston, TX 77058
     Main:  (281) 228-7262
     Fax:  (281) 218-9332
     ir@cyberonics.com



                       CYBERONICS, INC. AND SUBSIDIARY
                     CONDENSED CONSOLIDATED BALANCE SHEET

                                                October 24,        April 25,
                                                    2008             2008
                                                (Unaudited)
                     ASSETS
    Current Assets:
       Cash and cash equivalents                $69,340,855      $91,058,692
       Restricted cash                            1,000,000        1,000,000
       Accounts receivable, net                  20,155,709       20,039,832
       Inventories                               12,580,660       12,829,710
       Other current assets                       1,991,727        2,108,185
          Total Current Assets                  105,068,951      127,036,419
       Property a
'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results
2. Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
3. Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike
4. Cyberonics to Present at UBS Global Life Sciences Conference
5. Cyberonics to Present at Canaccord Adams 28th Annual Global Growth Conference
6. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
7. Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
8. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results
9. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
10. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
11. Cyberonics Licenses Obesity-Related Patents
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:The 50 Million Pound Challenge Announces One-Millionth Member 2Health News:The 50 Million Pound Challenge Announces One-Millionth Member 3Health News:ReGear Life Sciences Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc. 2Health News:Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now 2Health News:Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now 3Health News:EMU Receives $634,000 Grant From State to Help Stem Nursing Shortage 2Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 2Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 3Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 4Health News:House Republican Leader Boehner Says CMS Policies on Home Oxygen Therapy Will 'Potentially Harm' Care Available to Medicare Beneficiaries 2